Stock Analysis

Else Nutrition Holdings Second Quarter 2023 Earnings: CA$0.032 loss per share (vs CA$0.013 loss in 2Q 2022)

TSX:BABY
Source: Shutterstock

Else Nutrition Holdings (TSE:BABY) Second Quarter 2023 Results

Key Financial Results

  • Revenue: CA$2.37m (up 2.8% from 2Q 2022).
  • Net loss: CA$3.65m (loss widened by 167% from 2Q 2022).
  • CA$0.032 loss per share (further deteriorated from CA$0.013 loss in 2Q 2022).
earnings-and-revenue-history
TSX:BABY Earnings and Revenue History August 16th 2023

All figures shown in the chart above are for the trailing 12 month (TTM) period

Else Nutrition Holdings Earnings Insights

Looking ahead, revenue is forecast to grow 72% p.a. on average during the next 2 years, compared to a 4.7% growth forecast for the Food industry in Canada.

Performance of the Canadian Food industry.

The company's shares are down 25% from a week ago.

Risk Analysis

We should say that we've discovered 3 warning signs for Else Nutrition Holdings (2 are potentially serious!) that you should be aware of before investing here.

If you're looking to trade Else Nutrition Holdings, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.

With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.

Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.

Sponsored Content

Valuation is complex, but we're here to simplify it.

Discover if Else Nutrition Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.